Burning, stinging or pain in 1.5% of patients; itching in 1% of patients; rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis and increased exudate in <1% of patients. Systemic reactions to mupirocin have occurred rarely.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education